Teaser Image JMCP Cover Image Teaser Text A retrospective claims data analysis published in JMCP found that patients with metastatic melanoma treated with PD-1 had substantially lower costs than patients treated with other first line agents. Tags (Topics): Health Economics & Outcomes Research , Quality Care URL https://www.jmcp.org/doi/abs/10.18553/jmcp.2019.18442 Primary Taxonomy Tag Real World Evidence & Research
